55304-02-4 Usage
Description
Soyasaponin III is a saponin compound found in ground soybeans, known for its potential health benefits and therapeutic properties. It is a natural product with a unique chemical structure that contributes to its various applications.
Uses
Used in Pharmaceutical Industry:
Soyasaponin III is used as a therapeutic agent for preventing or treating diabetes mellitus. It has been shown to have beneficial effects on blood sugar levels and insulin sensitivity, making it a promising candidate for the development of treatments for diabetes-related conditions.
Used in Functional Foods and Supplements:
Soyasaponin III can also be utilized as an ingredient in functional foods and dietary supplements, targeting individuals looking to improve their overall health and well-being, particularly in the context of blood sugar management and cardiovascular health. Its natural origin and potential health benefits make it an attractive option for consumers seeking natural alternatives to synthetic medications.
Check Digit Verification of cas no
The CAS Registry Mumber 55304-02-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,3,0 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 55304-02:
(7*5)+(6*5)+(5*3)+(4*0)+(3*4)+(2*0)+(1*2)=94
94 % 10 = 4
So 55304-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C42H68O14/c1-37(2)16-21-20-8-9-24-39(4)12-11-26(40(5,19-44)23(39)10-13-42(24,7)41(20,6)15-14-38(21,3)25(45)17-37)54-36-33(30(49)29(48)32(55-36)34(51)52)56-35-31(50)28(47)27(46)22(18-43)53-35/h8,21-33,35-36,43-50H,9-19H2,1-7H3,(H,51,52)/t21-,22-,23?,24?,25+,26?,27+,28+,29-,30+,31-,32+,33-,35+,36-,38-,39+,40?,41-,42-/m1/s1
55304-02-4Relevant articles and documents
Partial hydrolysis of soyasaponin I and the hepatoprotective effects of the hydrolytic products. Study of the structure-hepatoprotective relationship of soyasapogenol B analogs
Ikeda, Tsuyoshi,Udayama, Manabu,Okawa, Masafumi,Arao, Tomonori,Kinjo, Junei,Nohara, Toshihiro
, p. 359 - 361 (1998)
As a part of our studies of hepatoprotective drugs, we prepared some soyasapogenol B analogs from soyasaponin I. We examined the hepatoprotective effects of these analogs, using immunologically-induced liver injury, in primary cultured rat hepatocytes. Soyasaponin III and soyasapogenol B monoglucuronide were more effective than soyasaponin I. Both compounds were significantly effective even at 30μM. The action of soyasapogenol B was almost equal to that of soyasaponin I, although glucuronic acid did not show any activity even at the highest dose (500μM). When the two compounds were mixed, the hepatoprotective action did not change, compared with soyasapogenol B. Therefore, we concluded that the linkage between glucuronic acid and soyasapogenol B could enhance the hepatoprotective activity.